Nuvation Bio Stock Market Value
| NUVB Stock | USD 2.74 0.04 1.48% |
| Symbol | Nuvation |
Nuvation Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.18) | Revenue Per Share 0.009 | Return On Assets (0.14) | Return On Equity (0.96) |
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nuvation Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nuvation Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nuvation Bio.
| 10/23/2024 |
| 11/22/2024 |
If you would invest 0.00 in Nuvation Bio on October 23, 2024 and sell it all today you would earn a total of 0.00 from holding Nuvation Bio or generate 0.0% return on investment in Nuvation Bio over 30 days. Nuvation Bio is related to or competes with Lyra Therapeutics, Hookipa Pharma, SAB Biotherapeutics, Cadrenal Therapeutics,, Monopar Therapeutics, Spero Therapeutics, and Bolt Biotherapeutics. Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for ... More
Nuvation Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nuvation Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nuvation Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.75 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 21.3 | |||
| Value At Risk | (8.36) | |||
| Potential Upside | 9.48 |
Nuvation Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nuvation Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nuvation Bio's standard deviation. In reality, there are many statistical measures that can use Nuvation Bio historical prices to predict the future Nuvation Bio's volatility.| Risk Adjusted Performance | 0.0179 | |||
| Jensen Alpha | (0.33) | |||
| Total Risk Alpha | (0.58) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0131 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nuvation Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nuvation Bio Backtested Returns
Nuvation Bio has Sharpe Ratio of -0.0245, which conveys that the firm had a -0.0245% return per unit of risk over the last 3 months. Nuvation Bio exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nuvation Bio's Mean Deviation of 3.71, downside deviation of 4.75, and Risk Adjusted Performance of 0.0179 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 3.86, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nuvation Bio will likely underperform. At this point, Nuvation Bio has a negative expected return of -0.12%. Please make sure to verify Nuvation Bio's skewness, and the relationship between the potential upside and rate of daily change , to decide if Nuvation Bio performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.06 |
Very weak reverse predictability
Nuvation Bio has very weak reverse predictability. Overlapping area represents the amount of predictability between Nuvation Bio time series from 23rd of October 2024 to 7th of November 2024 and 7th of November 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nuvation Bio price movement. The serial correlation of -0.06 indicates that barely 6.0% of current Nuvation Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.06 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
Nuvation Bio lagged returns against current returns
Autocorrelation, which is Nuvation Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nuvation Bio's stock expected returns. We can calculate the autocorrelation of Nuvation Bio returns to help us make a trade decision. For example, suppose you find that Nuvation Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nuvation Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nuvation Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nuvation Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nuvation Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Nuvation Bio Lagged Returns
When evaluating Nuvation Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nuvation Bio stock have on its future price. Nuvation Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nuvation Bio autocorrelation shows the relationship between Nuvation Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Nuvation Bio.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Nuvation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuvation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuvation Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nuvation Bio Stock:Check out Nuvation Bio Correlation, Nuvation Bio Volatility and Nuvation Bio Alpha and Beta module to complement your research on Nuvation Bio. For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Nuvation Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.